Condition
VEXAS Syndrome clinical trials and research
As of November 12, 2026, Find a Trial lists 5 VEXAS Syndrome clinical trials that are recruiting, at sites in 27 countries (most in Germany (3), United States (2), Italy (2)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 27Countries
Newest VEXAS Syndrome clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Arumakimig (MAS825) in VEXAS syndrome: 52 weeks to see if it helps people on steroids | Phase 2 | Yokohama, Kanagawa and 5 other locations | Recruiting | Aug 6, 2026 |
| Assessing the effectiveness of pacritinib for VEXAS syndrome | Phase 2 | Scottsdale, Arizona and 38 other locations | Recruiting | Jan 17, 2025 |
| Using pacritinib to treat VEXAS syndrome | Phase 1 | St Louis, Missouri | Recruiting | Aug 5, 2024 |
| National registry for patients with VEXAS syndrome | — | Aachen and 16 other locations | Recruiting | Apr 22, 2024 |
| Registry for hereditary autoinflammatory diseases | — | Algiers and 111 other locations | Recruiting | Jan 21, 2022 |
All recruiting trials (5)
-
Arumakimig (MAS825) in VEXAS syndrome: 52 weeks to see if it helps people on steroids
This study tests whether arumakimig can help adults with VEXAS syndrome who are taking glucocorticoids, compared with a placebo, over a year (with an option for a long-term extension).
-
Assessing the effectiveness of pacritinib for VEXAS syndrome
This study is testing if the drug pacritinib can help people with VEXAS syndrome manage their symptoms better while reducing their need for steroids.
-
Using pacritinib to treat VEXAS syndrome
This study is testing if the drug pacritinib can help people with VEXAS syndrome feel better and manage their symptoms.
-
National registry for patients with VEXAS syndrome
This study is collecting real-life information from adults with VEXAS syndrome to see how the disease behaves, what treatments work best, and to find important markers for diagnosis.
-
Registry for hereditary autoinflammatory diseases
This study is collecting information about hereditary autoinflammatory diseases to see how they affect patients of different ages and genders, with the goal of improving treatment and care for everyone affected.
Related topics
Quick answers
How many VEXAS Syndrome clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 27 countries. The most sites are in Germany (3 trials), United States (2 trials), Italy (2 trials), Spain (2 trials), Japan (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.